Cloud Capital Management’s Royalty Pharma RPRX Stock Holding History

Cloud Capital Management’s Portfolio RPRX Stock Details RPRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-6	Closed	–	–	1208
2025 Q3	$0	Buy	+6	New	+$217	﹤0.01%	1429

Other funds holding RPRX

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Cloud Capital Management's RPRX Position: Q4 2025 in Review

Cloud Capital Management sold out of Royalty Pharma (RPRX) in Q4 2025, closing a stake of 6 shares.

Cloud Capital Management first reported a position in RPRX in Q3 2025 and held it in 1 quarter. The position peaked at $0 in Q3 2025. 538 funds tracked by Wall St. Rank hold RPRX as of Q4 2025.

Cloud Capital Management reported no remaining Royalty Pharma position as of Q4 2025 after selling out during the quarter.
Cloud Capital Management sold 6 Royalty Pharma shares in Q4 2025.
Cloud Capital Management first reported a position in Royalty Pharma in Q3 2025 and held it in 1 quarter.
Cloud Capital Management's Royalty Pharma position peaked at $0 in Q3 2025.
538 funds tracked by Wall St. Rank held Royalty Pharma as of Q4 2025.

Based on Cloud Capital Management's 13F filing for Q4 2025, filed 12 Feb 2026.